These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 32830221)

  • 1. Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study.
    Horsager J; Andersen KB; Knudsen K; Skjærbæk C; Fedorova TD; Okkels N; Schaeffer E; Bonkat SK; Geday J; Otto M; Sommerauer M; Danielsen EH; Bech E; Kraft J; Munk OL; Hansen SD; Pavese N; Göder R; Brooks DJ; Berg D; Borghammer P
    Brain; 2020 Oct; 143(10):3077-3088. PubMed ID: 32830221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study.
    Knudsen K; Fedorova TD; Hansen AK; Sommerauer M; Otto M; Svendsen KB; Nahimi A; Stokholm MG; Pavese N; Beier CP; Brooks DJ; Borghammer P
    Lancet Neurol; 2018 Jul; 17(7):618-628. PubMed ID: 29866443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetric Dopaminergic Dysfunction in Brain-First versus Body-First Parkinson's Disease Subtypes.
    Knudsen K; Fedorova TD; Horsager J; Andersen KB; Skjærbæk C; Berg D; Schaeffer E; Brooks DJ; Pavese N; Van Den Berge N; Borghammer P
    J Parkinsons Dis; 2021; 11(4):1677-1687. PubMed ID: 34334424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the noradrenergic system in Parkinson's disease: an 11C-MeNER PET and neuromelanin MRI study.
    Sommerauer M; Fedorova TD; Hansen AK; Knudsen K; Otto M; Jeppesen J; Frederiksen Y; Blicher JU; Geday J; Nahimi A; Damholdt MF; Brooks DJ; Borghammer P
    Brain; 2018 Feb; 141(2):496-504. PubMed ID: 29272343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain Glucose Metabolism Heterogeneity in Idiopathic REM Sleep Behavior Disorder and in Parkinson's Disease.
    Arnaldi D; Meles SK; Giuliani A; Morbelli S; Renken RJ; Janzen A; Mayer G; Jonsson C; Oertel WH; Nobili F; Leenders KL; Pagani M;
    J Parkinsons Dis; 2019; 9(1):229-239. PubMed ID: 30741687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain cholinergic alterations in idiopathic REM sleep behaviour disorder: a PET imaging study with
    Bedard MA; Aghourian M; Legault-Denis C; Postuma RB; Soucy JP; Gagnon JF; Pelletier A; Montplaisir J
    Sleep Med; 2019 Jun; 58():35-41. PubMed ID: 31078078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging progressive peripheral and central dysfunction in isolated REM sleep behaviour disorder after 3 years of follow-up.
    Fedorova TD; Knudsen K; Andersen KB; Horsager J; Skjærbæk C; Beier CP; Sommerauer M; Svendsen KB; Otto M; Borghammer P
    Parkinsonism Relat Disord; 2022 Aug; 101():99-104. PubMed ID: 35853349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson's disease.
    Doppler CEJ; Kinnerup MB; Brune C; Farrher E; Betts M; Fedorova TD; Schaldemose JL; Knudsen K; Ismail R; Seger AD; Hansen AK; Stær K; Fink GR; Brooks DJ; Nahimi A; Borghammer P; Sommerauer M
    Brain; 2021 Oct; 144(9):2732-2744. PubMed ID: 34196700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered sensorimotor cortex noradrenergic function in idiopathic REM sleep behaviour disorder - A PET study.
    Andersen KB; Hansen AK; Sommerauer M; Fedorova TD; Knudsen K; Vang K; Van Den Berge N; Kinnerup M; Nahimi A; Pavese N; Brooks DJ; Borghammer P
    Parkinsonism Relat Disord; 2020 Jun; 75():63-69. PubMed ID: 32480309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symmetric and Profound Monoaminergic Degeneration in Parkinson's Disease with Premotor REM Sleep Behavior Disorder.
    Woo KA; Kim HJ; Shin JH; Cho K; Choi H; Jeon B
    J Parkinsons Dis; 2024; 14(4):823-831. PubMed ID: 38640171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network degeneration in Parkinson's disease: multimodal imaging of nigro-striato-cortical dysfunction.
    Ruppert MC; Greuel A; Tahmasian M; Schwartz F; Stürmer S; Maier F; Hammes J; Tittgemeyer M; Timmermann L; van Eimeren T; Drzezga A; Eggers C
    Brain; 2020 Mar; 143(3):944-959. PubMed ID: 32057084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder.
    Stefani A; Iranzo A; Holzknecht E; Perra D; Bongianni M; Gaig C; Heim B; Serradell M; Sacchetto L; Garrido A; Capaldi S; Sánchez-Gómez A; Cecchini MP; Mariotto S; Ferrari S; Fiorini M; Schmutzhard J; Cocchiara P; Vilaseca I; Brozzetti L; Monaco S; Jose Marti M; Seppi K; Tolosa E; Santamaria J; Högl B; Poewe W; Zanusso G;
    Brain; 2021 May; 144(4):1118-1126. PubMed ID: 33855335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain-First versus Gut-First Parkinson's Disease: A Hypothesis.
    Borghammer P; Van Den Berge N
    J Parkinsons Dis; 2019; 9(s2):S281-S295. PubMed ID: 31498132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging acetylcholinesterase density in peripheral organs in Parkinson's disease with 11C-donepezil PET.
    Gjerløff T; Fedorova T; Knudsen K; Munk OL; Nahimi A; Jacobsen S; Danielsen EH; Terkelsen AJ; Hansen J; Pavese N; Brooks DJ; Borghammer P
    Brain; 2015 Mar; 138(Pt 3):653-63. PubMed ID: 25539902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermal and cardiac autonomic fiber involvement in Parkinson's disease and multiple system atrophy.
    Brumberg J; Kuzkina A; Lapa C; Mammadova S; Buck A; Volkmann J; Sommer C; Isaias IU; Doppler K
    Neurobiol Dis; 2021 Jun; 153():105332. PubMed ID: 33722614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A New Metabolic Network Correlated with Olfactory and Executive Dysfunctions in Idiopathic Rapid Eye Movement Sleep Behavior Disorder.
    Yoon EJ; Lee JY; Nam H; Kim HJ; Jeon B; Jeong JM; Kim YK
    J Clin Neurol; 2019 Apr; 15(2):175-183. PubMed ID: 30877691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and imaging evidence of brain-first and body-first Parkinson's disease.
    Horsager J; Knudsen K; Sommerauer M
    Neurobiol Dis; 2022 Mar; 164():105626. PubMed ID: 35031485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of α-synuclein in submandibular glands of patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study.
    Vilas D; Iranzo A; Tolosa E; Aldecoa I; Berenguer J; Vilaseca I; Martí C; Serradell M; Lomeña F; Alós L; Gaig C; Santamaria J; Gelpi E
    Lancet Neurol; 2016 Jun; 15(7):708-718. PubMed ID: 27039162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of plasma α-synuclein with cardiac
    Park DG; Kang J; An YS; Chang J; Yoon JH
    Neurosci Lett; 2022 Jan; 770():136399. PubMed ID: 34921912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gray Matter Volume Loss in Proposed Brain-First and Body-First Parkinson's Disease Subtypes.
    Banwinkler M; Dzialas V; ; Hoenig MC; van Eimeren T
    Mov Disord; 2022 Oct; 37(10):2066-2074. PubMed ID: 35943058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.